Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells.

Sivaprasad U, Basu A.

J Cell Mol Med. 2008 Aug;12(4):1265-71. doi: 10.1111/j.1582-4934.2008.00282.x. Epub 2008 Feb 8.

2.

IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis.

Dhingra S, Sharma AK, Arora RC, Slezak J, Singal PK.

Cardiovasc Res. 2009 Apr 1;82(1):59-66. doi: 10.1093/cvr/cvp040. Epub 2009 Jan 30.

3.

Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione.

Fan Y, Chen H, Qiao B, Luo L, Ma H, Li H, Jiang J, Niu D, Yin Z.

Mol Cells. 2007 Feb 28;23(1):30-8.

5.
6.

Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.

Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH.

Biochem Pharmacol. 2012 Mar 15;83(6):747-57. doi: 10.1016/j.bcp.2011.12.029. Epub 2011 Dec 29.

PMID:
22226932
7.

Diphenyl diselenide induces apoptotic cell death and modulates ERK1/2 phosphorylation in human neuroblastoma SH-SY5Y cells.

Posser T, de Paula MT, Franco JL, Leal RB, da Rocha JB.

Arch Toxicol. 2011 Jun;85(6):645-51. doi: 10.1007/s00204-010-0602-0. Epub 2010 Oct 6.

PMID:
20924558
8.

Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.

Kauppinen TM, Chan WY, Suh SW, Wiggins AK, Huang EJ, Swanson RA.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):7136-41. Epub 2006 Apr 20.

9.

ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.

Liu J, Mao W, Ding B, Liang CS.

Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1956-65. doi: 10.1152/ajpheart.00407.2008. Epub 2008 Sep 5.

10.

Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.

Hans CP, Zerfaoui M, Naura AS, Catling A, Boulares AH.

Cardiovasc Res. 2008 Jun 1;78(3):429-39. doi: 10.1093/cvr/cvn018. Epub 2008 Jan 31.

12.

Compensatory activation of ERK1/2 in Atg5-deficient mouse embryo fibroblasts suppresses oxidative stress-induced cell death.

Pyo JO, Nah J, Kim HJ, Lee HJ, Heo J, Lee H, Jung YK.

Autophagy. 2008 Apr;4(3):315-21. Epub 2008 Jan 7.

PMID:
18196969
13.

Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α.

Kanaji N, Nelson A, Wang X, Sato T, Nakanishi M, Gunji Y, Basma H, Michalski J, Farid M, Rennard SI, Liu X.

J Vasc Res. 2013;50(2):145-56. doi: 10.1159/000345525. Epub 2012 Dec 18.

PMID:
23258237
15.

SOCS-1 inhibits TNF-alpha-induced cardiomyocyte apoptosis via ERK1/2 pathway activation.

Yan L, Tang Q, Shen D, Peng S, Zheng Q, Guo H, Jiang M, Deng W.

Inflammation. 2008 Jun;31(3):180-8. doi: 10.1007/s10753-008-9063-5. Epub 2008 Mar 11.

PMID:
18330685
16.

Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2.

Kilpatrick LE, Sun S, Mackie D, Baik F, Li H, Korchak HM.

J Leukoc Biol. 2006 Dec;80(6):1512-21. Erratum in: J Leukoc Biol. 2008 Mar;83(3):797.

PMID:
17138860
17.

ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells.

Nguyen TH, Mustafa FB, Pervaiz S, Ng FS, Lim LH.

Int J Oncol. 2008 Jul;33(1):81-92.

PMID:
18575753
18.

The inhibition of ERK activation mediates the protection of necrostatin-1 on glutamate toxicity in HT-22 cells.

Zhang M, Li J, Geng R, Ge W, Zhou Y, Zhang C, Cheng Y, Geng D.

Neurotox Res. 2013 Jul;24(1):64-70. doi: 10.1007/s12640-012-9361-4. Epub 2013 Jan 10.

PMID:
23307752
19.

Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.

Li P, Tian W, Ma X.

Mol Cancer. 2014 Jun 3;13:138. doi: 10.1186/1476-4598-13-138.

20.

Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.

Liu L, Li W, Li Z, Kirschfink M.

Clin Exp Immunol. 2012 Aug;169(2):100-8. doi: 10.1111/j.1365-2249.2012.04596.x.

Items per page

Supplemental Content

Write to the Help Desk